Ann Arbor Stage I Diffuse Large B-Cell Lymphoma
2 clinical trials · Condition
◉ Watch Ann Arbor Stage I Diffuse Large B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma (NCT04139304) | AIDS Malignancy Consortium | 2021-05-24 |
| Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas (NCT01193842) | National Cancer Institute (NCI) | 2010-10-06 |
Track Ann Arbor Stage I Diffuse Large B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.